Search





Search





Markets
/
Stocks
/
tngx
/

Tango Therapeutics Inc

TNGX

Add to Watchlist

27.180USD

-0.390-1.41%

Close 07-31 16:00（ET）Quotes delayed by 15 min

4.41BMarket Cap

LossP/E TTM

Tango Therapeutics Inc

27.180

-0.390-1.41%

Financial Summary Income Statement Balance Sheet Cash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial Summary Income Statement Balance Sheet Cash Flow Statement

TNGX Cash Flow Statement

You can access the annual and quarterly cash flow statements of Tango Therapeutics Inc to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

Operating cash flows (indirect method)

Cash flow from continuing operating activities

-6.39%-44.36M

18.91%-29.72M

7.30%-30.95M

-54.70%-36.52M

-10.14%-41.70M

-33.42%-36.65M

-7.24%-33.39M

3.54%-23.61M

-8.45%-37.86M

2.83%-27.47M

-58.76%-31.14M

22.40%-24.47M

-17.67%-34.91M

-67.23%-28.27M

53.15%-19.61M

-4354.32%-31.54M

-53226.50%-29.66M

-6997.45%-16.90M

-46803.99%-41.86M

---708.03K

---55.63K

---238.14K

---89.25K

Net income from continuing operations

-14.14%-45.51M

-2.86%-38.75M

154.46%15.88M

-52.06%-38.85M

-5.17%-39.88M

-22.45%-37.67M

-31.01%-29.17M

-23.38%-25.55M

-35.37%-37.91M

-5.86%-30.76M

23.36%-22.26M

16.69%-20.71M

-11.11%-28.01M

-31.82%-29.06M

17.44%-29.05M

-3151.11%-24.86M

-10414.11%-25.21M

-31311.72%-22.05M

-67059.09%-35.18M

---764.60K

---239.75K

---70.18K

---52.39K

Operating gains losses

-25.56%463.00K

-22.74%479.00K

-10.77%555.00K

-1.11%625.00K

-0.48%622.00K

0.49%620.00K

1.47%622.00K

4.64%632.00K

7.57%625.00K

8.25%617.00K

47.00%613.00K

93.59%604.00K

88.03%581.00K

122.66%570.00K

--417.00K

--312.00K

--309.00K

--256.00K

----

Other non-cash items

-141.19%-131.00K

94.32%171.00K

268.16%412.00K

225.00%295.00K

169.74%318.00K

106.07%88.00K

-114.65%-245.00K

-1083.33%-236.00K

-3700.00%-456.00K

-447.72%-1.45M

186.30%1.67M

-92.84%24.00K

-102.89%-12.00K

3.22%417.00K

107.42%584.00K

--335.00K

--415.00K

--404.00K

---7.88M

----

Change in working capital

0.41%-9.97M

133.59%2.40M

-362.12%-54.43M

13.92%-5.16M

-46.63%-10.02M

-852.93%-7.15M

26.47%-11.78M

37.03%-5.99M

41.55%-6.83M

81.15%-750.00K

-446.46%-16.02M

11.53%-9.51M

-39.36%-11.69M

-278.63%-3.98M

296.48%4.62M

-17385.06%-10.75M

-4078.35%-8.39M

2043.74%2.23M

4762.34%1.17M

--62.20K

--210.79K

---114.57K

---25.01K

-Change in receivables

----

--0.00

-100.00%0.00

--0.00

--2.00M

----

--6.00M

----

-Change in prepaid expenses

-454.24%-2.30M

139.37%350.00K

-33.33%-1.65M

-151.92%-1.11M

80.28%649.00K

-165.51%-889.00K

-10.62%-1.24M

566.04%2.14M

112.94%360.00K

279.26%1.36M

-109.87%-1.12M

103.58%321.00K

24.52%-2.78M

-1301.59%-757.00K

448.69%11.35M

-21702.01%-8.96M

-39409.22%-3.69M

155.32%63.00K

-4574.21%-3.25M

--41.47K

---9.33K

---113.88K

---69.62K

-Change in other current assets

900.00%10.00K

-244.44%-13.00K

1100.00%20.00K

-30800.00%-307.00K

-97.14%1.00K

800.00%9.00K

94.29%-2.00K

-83.33%1.00K

369.23%35.00K

-98.31%1.00K

99.65%-35.00K

50.00%6.00K

-425.00%-13.00K

137.58%59.00K

---10.07M

--4.00K

---157.00K

----

-Change in other current liabilities

----

100.00%0.00

-363.65%-53.81M

59.09%-3.18M

16.67%-5.39M

24.19%-4.12M

-8.14%-11.61M

18.99%-7.78M

-12.23%-6.47M

-23.12%-5.43M

-118.13%-10.73M

-154.52%-9.60M

-53.43%-5.77M

-18.70%-4.41M

-162329.84%-4.92M

-17784.75%-3.77M

-15684.31%-3.76M

-126812.57%-3.72M

-108.53%-3.03K

---21.09K

--24.11K

---2.93K

--35.49K

Cash from non-recurring investing activities

Cash from operating activities

-6.39%-44.36M

18.91%-29.72M

7.30%-30.95M

-54.70%-36.52M

-10.14%-41.70M

-33.42%-36.65M

-7.24%-33.39M

3.54%-23.61M

-8.45%-37.86M

2.83%-27.47M

-58.76%-31.14M

22.40%-24.47M

-17.67%-34.91M

-67.23%-28.27M

53.15%-19.61M

-4354.32%-31.54M

-53226.50%-29.66M

-6997.45%-16.90M

-46803.99%-41.86M

---708.03K

---55.63K

---238.14K

---89.25K

Investing cash flow

Net cash from continuing investing activities

-103.92%-2.00K

79.03%222.00K

31.30%151.00K

95.00%624.00K

-73.85%51.00K

-45.13%124.00K

618.75%115.00K

-51.81%320.00K

-68.55%195.00K

-78.29%226.00K

-99.51%16.00K

-63.34%664.00K

-60.28%620.00K

49.57%1.04M

--3.28M

--1.81M

--1.56M

--696.00K

----

Capital expenditures

-96.08%2.00K

79.03%222.00K

31.30%151.00K

95.00%624.00K

-73.85%51.00K

-45.13%124.00K

618.75%115.00K

-51.81%320.00K

-68.55%195.00K

-78.29%226.00K

-99.51%16.00K

-63.34%664.00K

-60.28%620.00K

49.57%1.04M

--3.28M

--1.81M

--1.56M

--696.00K

----

Net cash flow from disposal of fixed assets

-103.92%-2.00K

79.03%222.00K

31.30%151.00K

95.00%624.00K

-73.85%51.00K

-45.13%124.00K

618.75%115.00K

-51.81%320.00K

-68.55%195.00K

-78.29%226.00K

-99.51%16.00K

-63.34%664.00K

-60.28%620.00K

49.57%1.04M

--3.28M

--1.81M

--1.56M

--696.00K

----

Net cash flow from investment products

-68.57%9.63M

-359.65%-135.50M

45.72%47.63M

33.67%17.40M

378.42%30.65M

53.13%52.18M

157.70%32.69M

-60.96%13.02M

-134.22%-11.01M

394.69%34.08M

-406.09%-56.65M

-10.60%33.35M

416.77%32.17M

74.02%-11.56M

--18.51M

--37.30M

---10.16M

---44.51M

----

--0.00

---166.75M

Net cash flow from other investing activities

--4.00K

--0.00

----

---138.26M

----

Cash from non-current investing activities

Net cash flow from investing activities

-68.51%9.63M

-360.69%-135.72M

45.77%47.48M

32.12%16.78M

373.11%30.60M

53.79%52.06M

157.48%32.57M

-61.15%12.70M

-135.51%-11.20M

368.56%33.85M

-472.10%-56.66M

-7.91%32.69M

369.28%31.55M

72.12%-12.61M

111.01%15.23M

109065.56%35.49M

---11.72M

---45.21M

17.09%-138.26M

--32.51K

----

--0.00

---166.75M

Financing cash flow

Cash flow from continuous financing activities

3992200.00%79.85M

22539.42%219.38M

5.79%2.54M

-55.68%581.00K

-100.00%2.00K

-33.95%969.00K

-97.01%2.40M

123.72%1.31M

58779.45%42.98M

178.37%1.47M

70944.25%80.28M

-18.38%586.00K

-71.60%73.00K

539.17%527.00K

-99.97%113.00K

--718.00K

--257.00K

---120.00K

112.30%357.44M

----

--0.00

--168.37M

Net cash flow from debt Issuance/repayment

----

--0.00

Net cash flow from common stock issuance/repurchase

4019050.00%80.38M

22543.14%219.41M

5.79%2.54M

-55.68%581.00K

-100.00%2.00K

15.22%969.00K

-97.01%2.40M

123.72%1.31M

58779.45%42.98M

59.58%841.00K

71101.77%80.46M

-18.38%586.00K

-72.45%73.00K

421.78%527.00K

--113.00K

--718.00K

--265.00K

--101.00K

----

--0.00

--172.09M

Net cash flow from preferred stock issuance/repurchase

----

--0.00

----

Net cash flow from other financing activities

---537.00K

---36.00K

----

--626.00K

---178.00K

--0.00

100.00%0.00

--0.00

---8.00K

---221.00K

----

--0.00

---3.72M

Net cash from non-recurrent financing activities

Net cash from financing activities

3992200.00%79.85M

22539.42%219.38M

5.79%2.54M

-55.68%581.00K

-100.00%2.00K

-33.95%969.00K

-97.01%2.40M

123.72%1.31M

58779.45%42.98M

178.37%1.47M

70944.25%80.28M

-18.38%586.00K

-71.60%73.00K

539.17%527.00K

-99.97%113.00K

--718.00K

--257.00K

---120.00K

112.30%357.44M

----

--0.00

--168.37M

Net cash flow

Beginning cash balance

59.29%114.85M

9.32%60.91M

-22.71%41.84M

-4.29%61.00M

3.28%72.10M

-10.07%55.72M

-22.08%54.13M

5.04%63.73M

9.15%69.81M

-40.60%61.96M

-36.01%69.47M

-41.60%60.67M

-55.90%63.96M

-49.67%104.30M

262.77%108.57M

8156.07%103.90M

10936.12%145.02M

13251.98%207.25M

119648.94%29.93M

--1.26M

--1.31M

--1.55M

--24.99K

Current period cash flow changes

506.57%45.12M

229.27%53.94M

1105.18%19.07M

-99.65%-19.16M

-82.59%-11.10M

108.63%16.38M

121.04%1.58M

-209.06%-9.60M

-85.14%-6.08M

119.46%7.85M

-76.09%-7.52M

88.32%8.80M

92.02%-3.28M

35.17%-40.34M

-102.41%-4.27M

791.77%4.67M

-73827.27%-41.13M

-26031.05%-62.23M

11510.80%177.32M

---675.52K

---55.63K

---238.14K

--1.53M

Ending cash balance

162.25%159.97M

59.29%114.85M

9.32%60.91M

-22.71%41.84M

-4.29%61.00M

3.28%72.10M

-10.07%55.72M

-22.08%54.13M

5.04%63.73M

9.15%69.81M

-40.60%61.96M

-36.01%69.47M

-41.60%60.67M

-55.90%63.96M

-49.67%104.30M

18524.97%108.57M

8156.07%103.90M

10936.12%145.02M

13251.98%207.25M

--582.94K

--1.26M

--1.31M

--1.55M

Free cash flow

-6.26%-44.36M

18.58%-29.94M

7.17%-31.10M

-55.23%-37.14M

-9.71%-41.75M

-32.78%-36.77M

-7.56%-33.51M

4.81%-23.93M

-7.11%-38.05M

5.51%-27.69M

-36.09%-31.15M

24.62%-25.14M

-13.77%-35.53M

-66.54%-29.31M

45.32%-22.89M

---33.35M

---31.23M

-7289.71%-17.60M

-46803.99%-41.86M

----

---238.14K

---89.25K

Currency unit

--USD

Audit opinions

----

FAQs

What is operating cash flow?



Operating cash flow is the cash generated or used by a company's core business operations. It adjusts net income for non-cash items and working capital changes, such as depreciation, receivables, inventory, and payables. Strong operating cash flow can indicate that the business is converting sales and earnings into real cash.

How Much Operating Cash Flow Did Tango Therapeutics Inc Generate?



Tango Therapeutics Inc generated -138.89M in operating cash flow in fiscal 2025, reflecting cash generated from its core business operations.

How Did Tango Therapeutics Inc's Operating Cash Flow Change Year Over Year?



Tango Therapeutics Inc's operating cash flow increased by -5.62% year over year.

What is investing cash flow?



Investing cash flow shows cash used for or generated from investment-related activities, such as capital expenditures, purchases or sales of investments, acquisitions, and asset disposals. Negative investing cash flow is not always bad, because it can reflect spending on future growth, but investors should check whether those investments support long-term returns.

How Much Does Tango Therapeutics Inc Spend on Capital Expenditures?



Tango Therapeutics Inc spent 1.05M on capital expenditures in the most recent quarter。

What is financing cash flow?



Financing cash flow shows how a company raises capital or returns capital to investors and creditors. It can include debt issuance, debt repayment, share issuance, share repurchases, dividend payments, and lease financing. Positive financing cash flow may show new capital raised, while negative financing cash flow may reflect debt repayment, dividends, or buybacks.

How Has Tango Therapeutics Inc's Financing Cash Flow Changed?



Tango Therapeutics Inc used 222.50M in financing activities in the latest quarter.

What is free cash flow and why does it matter for TNGX?



Free cash flow is the cash a company has left after funding the capital spending needed to maintain or grow the business. It is often used to assess financial flexibility, debt repayment capacity, dividend sustainability, buyback potential, and valuation quality. Investors should compare free cash flow with net income, revenue growth, and capital expenditures.

What was Tango Therapeutics Inc’s free cash flow in the latest quarter?



Free cash flow was -139.93M reflecting a -5.81% change from the previous year.